好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Low-Dose Mitoxantrone as Add-On Therapy in Multiple Sclerosis Unresponsive to Interferon-beta
MS and Related Diseases
(-)
170
Authors/Disclosures
Davide Maimone, MD, PhD (Neurology Unit, Ospedale Garibaldi - Catania) Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Maimone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva.
No disclosure on file
Ismael Ramadan Ali No disclosure on file
Giuseppe Zappala, MD (Azienda Ospedaliera Garibaldi) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file